UT Southwestern Medical Center | Icebreaker

Sign up or Log in

Teams

System

UT Southwestern Medical Center | Icebreaker

UT Southwestern Medical Center

UT Southwestern Medical Center

Developed in partnership with the Texas Health and Human Services Commission, the state-funded facility – the first of its kind in DFW – is slated to open this summer.

15 members

Contact info

Link

utsouthwestern.edu

Members

•

Associate Staff, Vascular & Interventional Radiology

Denver Baumgartner

•

Senior Researcher

Roman Stolyarov, PhD

•

I develop and commercialize medical devices.

Christopher Kethley, MBA

•

Searching for my next opportunity to bring value

•

I am a translational researcher committed to advancing novel cellular therapies and immunotherapies to treat children and young adults with cancer and blood disorders. I will collaborate with other researchers to open cutting-edge clinical trials and offer new therapies to patients who have exhausted standard treatment approaches. I treat patients with solid tumors and patients receiving bone marrow transplants.

Viktoria Korzhova

•

Product & Ops @ Product People 🧠 Fueled with Neuroscience - Interim Product Managers for parental leaves or while you are hiring 🍙

Ed Esplin, MD, PhD, FACMG, CGAF, FACP

•

Dr. Esplin is a physician-scientist board certified in Clinical Genetics and Internal Medicine with a focus on using comprehensive germline and solid-tumor somatic genomic information to provide patients with cancer, cardiomyopathy, epilepsy and other rare diseases access to precision therapies and clinical trials to improve care for patients, and genomic screening to identify modifiable genetic disease risks in healthy individuals. Medical Officer at Invitae for 10 years, joining in its start-up phase and continuing through its successful IPO and subsequent acquisition, he was a key stakeholder in securing first of its kind FDA de novo market authorization for the Invitae Common Hereditary Cancers panel, an in vitro diagnostic test. He currently leads clinical trials and research at Labcorp Genetics (formerly Invitae) including the INTERCEPT trial with Dr. Jewel Samadder at the Mayo Clinic; the PROCLAIM trial in prostate cancer with Dr. Neal Shore; the Universal Germline Testing in the Community trial (UNITY, NCT05416710) with Dr. Kashyap Patel; and Labcorp Genetics collaboration with the NIH funded eMERGE IV Consortium evaluating the clinical utility of genomic screening in healthy individuals. He has co-authored >100 scientific papers. Dr. Esplin completed the MSTP program at UT Southwestern obtaining his MD and PhD in Genetics, completed internal medicine residency training and served as an Assistant Professor of Internal Medicine at UT Southwestern. He subsequently completed clinical genetics training at Stanford University followed by an NIH-funded Tashia and John Morgridge Endowed Postdoctoral Fellowship with Mike Snyder in the Stanford Department of Genetics, where he maintains an academic appointment and is a consulting investigator for the Stanford Pre-Cancer Atlas as part of the NIH Human Tumor Atlas Network (HTAN). He serves on the ACMG Therapeutics Committee and is a fellow of the American College of Medical Genetics and Genomics (ACMG), the Collaborative Group of the Americas for Inherited Gastrointestinal Cancer (CGA-IGC) and the American College of Physicians (ACP). Specialties: Medical Genetics Preventional Genetics Cancer Genomics Genomic Medicine Internal Medicine

•

Associate Professor at The University of Texas Southwestern Medical Center

Dianne Risha Valera

•

QA @ Regeneron Pharmaceuticals

•

I pursue excellent product design through relationships, beauty, empathy, and research. Specialties: Interaction and service design, Agile/XP, paired design, UX research/strategy, client collaboration, wireframes/prototypes, product vision statements, branding, editorial photography, illustration, copywriting, and art direction.